About
Technology
Issues
FAQ
Links
Official Page
A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline
BRCA1/2
Mutations (ABRAZO)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.